Table of Contents
1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Definitions forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
2 Market Overview
2.1 Bifidobacterium Longum Introduction
2.2 Market Analysis by Type
2.2.1 0.2g/Piece
2.2.2 0.25g/Piece
2.3 Market Analysis by Applications
2.3.1 Medicine
2.3.2 Others
2.4 Market Analysis by Countries
2.4.1 United States Status and Prospect (2013-2026)
2.4.2 Mexico Status and Prospect (2013-2026)
2.4.3 Canada Status and Prospect (2013-2026)
2.5 Market Dynamics
2.5.1 Market Opportunities
2.5.2 Market Risk
2.5.3 Market Driving Force
2.6 Market Competition News and Trend
2.6.1 Merger, Consolidation or Acquisition News
2.6.2 Investment or Disinvestment News
2.6.3 New Product Development and Launch
3 North America Bifidobacterium Longum Market Competition, by Manufacturer
3.1 North America Bifidobacterium Longum Sales and Market Share by Manufacturer (2016-2018)
3.1.1 North America Bifidobacterium Longum Sales by Manufacturer (2016-2018)
3.1.2 North America Bifidobacterium Longum Sales Market Share by Manufacturer (2016-2018)
3.2 North America Bifidobacterium Longum Revenue and Market Share by Manufacturer (2016-2018)
3.2.1 North America Bifidobacterium Longum Revenue by Manufacturer (2016-2018)
3.2.2 North America Bifidobacterium Longum Revenue Market Share by Manufacturer (2016-2018)
3.3 North America Bifidobacterium Longum Price by Manufacturers (2016-2018)
3.4 Market Concentration Rate
3.4.1 Top 3 Bifidobacterium Longum Manufacturer Market Share (2016-2018)
3.4.2 Top 5 Bifidobacterium Longum Manufacturer Market Share (2016-2018)
3.5 Market Competition Trend
4 Manufacturers Profiles
4.1 ATCC Inc
4.1.1 Business Overview
4.1.2 Bifidobacterium Longum Type and Applications
4.1.2.1 Product A
4.1.2.2 Product B
4.1.3 ATCC Inc Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.2 BioGaia AB
4.2.1 Business Overview
4.2.2 Bifidobacterium Longum Type and Applications
4.2.2.1 Product A
4.2.2.2 Product B
4.2.3 BioGaia AB Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.3 Mystic Pharmaceuticals Inc
4.3.1 Business Overview
4.3.2 Bifidobacterium Longum Type and Applications
4.3.2.1 Product A
4.3.2.2 Product B
4.3.3 Mystic Pharmaceuticals Inc Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.4 Hanson Ltd
4.4.1 Business Overview
4.4.2 Bifidobacterium Longum Type and Applications
4.4.2.1 Product A
4.4.2.2 Product B
4.4.3 Hanson Ltd Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.5 Biofodan A/S
4.5.1 Business Overview
4.5.2 Bifidobacterium Longum Type and Applications
4.5.2.1 Product A
4.5.2.2 Product B
4.5.3 Biofodan A/S Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.6 BioCare Copenhagen ApS
4.6.1 Business Overview
4.6.2 Bifidobacterium Longum Type and Applications
4.6.2.1 Product A
4.6.2.2 Product B
4.6.3 BioCare Copenhagen ApS Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.7 Danisco A/S
4.7.1 Business Overview
4.7.2 Bifidobacterium Longum Type and Applications
4.7.2.1 Product A
4.7.2.2 Product B
4.7.3 Danisco A/S Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.8 Danone SA
4.8.1 Business Overview
4.8.2 Bifidobacterium Longum Type and Applications
4.8.2.1 Product A
4.8.2.2 Product B
4.8.3 Danone SA Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.9 Deerland Enzymes Inc.
4.9.1 Business Overview
4.9.2 Bifidobacterium Longum Type and Applications
4.9.2.1 Product A
4.9.2.2 Product B
4.9.3 Deerland Enzymes Inc. Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
5 North America Bifidobacterium Longum Market Analysis by Countries
5.1 North America Bifidobacterium Longum Sales and Market Share by Countries (2013-2018)
5.1.1 North America Bifidobacterium Longum Sales by Countries (2013-2018)
5.1.2 North America Bifidobacterium Longum Sales Market Share by Countries (2013-2018)
5.2 North America Bifidobacterium Longum Revenue (Value) and Market Share by Countries (2013-2018)
5.2.1 North America Bifidobacterium Longum Revenue by Countries (2013-2018)
5.2.2 North America Bifidobacterium Longum Revenue Market Share by Countries (2013-2018)
6 North America Market Segmentation Bifidobacterium Longum by Type
6.1 North America Bifidobacterium Longum Sales, Revenue and Market Share by Type (2013-2018)
6.1.1 North America Bifidobacterium Longum Sales and Market Share by Type (2013-2018)
6.1.2 North America Bifidobacterium Longum Revenue and Market Share by Type (2013-2018)
6.2 0.2g/Piece Sales Growth Rate and Price
6.2.1 North America 0.2g/Piece Sales Growth Rate (2013-2018)
6.2.2 North America 0.2g/Piece Price (2013-2018)
6.3 0.25g/Piece Sales Growth Rate and Price
6.3.1 North America 0.25g/Piece Sales Growth Rate (2013-2018)
6.3.2 North America 0.25g/Piece Price (2013-2018)
7 North America Market Segmentation Bifidobacterium Longum by Application
7.1 North America Bifidobacterium Longum Sales Market Share by Application (2013-2018)
7.2 Medicine Sales Growth Rate (2013-2018)
7.3 Others Sales Growth Rate (2013-2018)
8 United States Bifidobacterium Longum Sales, Revenue, by Type, Application and Manufacturers
8.1 United States Bifidobacterium Longum Revenue, Sales and Growth Rate (2013-2018)
8.2 United States Bifidobacterium Longum Sales and Market Share by Type
8.2.1 United States Bifidobacterium Longum Sales by Type (2013-2018)
8.2.2 United States Bifidobacterium Longum Sales Market Share by Type (2013-2018)
8.3 United States Bifidobacterium Longum Sales and Market Share by Application (2013-2018)
8.3.1 United States Bifidobacterium Longum Sales by Application (2013-2018)
8.3.2 United States Bifidobacterium Longum Sales Market Share by Application (2013-2018)
8.4 United States Bifidobacterium Longum Sales, Revenue and Market Share by Manufacturer (2016-2018)
8.4.1 United States Bifidobacterium Longum Sales and Market Share by Manufacturer (2016-2018)
8.4.2 United States Bifidobacterium Longum Revenue and Market Share by Manufacturer (2016-2018)
8.5 United States Bifidobacterium Longum Export and Import (2013-2018)
9 Canada Bifidobacterium Longum Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Bifidobacterium Longum Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Bifidobacterium Longum Sales and Market Share by Type (2013-2018)
9.2.1 Canada Bifidobacterium Longum Sales by Type (2013-2018)
9.2.2 Canada Bifidobacterium Longum Sales Market Share by Type (2013-2018)
9.3 Canada Bifidobacterium Longum Sales and Market Share by Application (2013-2018)
8.3.1 Canada Bifidobacterium Longum Sales by Application (2013-2018)
9.3.2 Canada Bifidobacterium Longum Sales Market Share by Application (2013-2018)
9.4 Canada Bifidobacterium Longum Sales, Revenue and Market Share by Manufacturer (2016-2018)
9.4.1 Canada Bifidobacterium Longum Sales and Market Share by Manufacturer (2016-2018)
9.4.2 Canada Bifidobacterium Longum Revenue and Market Share by Manufacturer (2016-2018)
9.5 Canada Bifidobacterium Longum Export and Import (2013-2018)
10 Mexico Bifidobacterium Longum Sales, Revenue, by Type, Application and Manufacturers
10.1 Mexico Bifidobacterium Longum Revenue, Sales and Growth Rate (2013-2018)
10.2 Mexico Bifidobacterium Longum Sales and Market Share by Type (2013-2018)
10.2.1 Mexico Bifidobacterium Longum Sales by Type (2013-2018)
10.2.2 Mexico Bifidobacterium Longum Sales Market Share by Type (2013-2018)
10.3 Mexico Bifidobacterium Longum Sales and Market Share by Application (2013-2018)
9.3.1 Mexico Bifidobacterium Longum Sales by Application (2013-2018)
10.3.2 Mexico Bifidobacterium Longum Sales Market Share by Application (2013-2018)
10.4 Mexico Bifidobacterium Longum Sales, Revenue and Market Share by Manufacturer (2016-2018)
10.4.1 Mexico Bifidobacterium Longum Sales and Market Share by Manufacturer (2016-2018)
10.4.2 Mexico Bifidobacterium Longum Revenue and Market Share by Manufacturer (2016-2018)
10.5 Mexico Bifidobacterium Longum Export and Import (2013-2018)
11 Bifidobacterium Longum Market Forecast (2019-2026)
11.1 North America Bifidobacterium Longum Sales, Revenue and Growth Rate (2019-2026)
11.2 Bifidobacterium Longum Market Forecast by Countries (2019-2026)
11.2.1 North America Bifidobacterium Longum Sales Forecast by Countries (2019-2026)
11.2.2 United States Bifidobacterium Longum Forecast (2019-2026)
11.2.3 Canada Bifidobacterium Longum Forecast (2019-2026)
11.2.4 Mexico Bifidobacterium Longum Forecast (2019-2026)
11.3 Bifidobacterium Longum Market Forecast by Type (2019-2026)
11.3.1 North America Bifidobacterium Longum Sales Forecast by Type (2019-2026)
11.3.2 North America Bifidobacterium Longum Market Share Forecast by Type (2019-2026)
11.4 Bifidobacterium Longum Market Forecast by Application (2019-2026)
11.4.1 North America Bifidobacterium Longum Sales Forecast by Application (2019-2026)
11.4.2 North America Bifidobacterium Longum Market Share Forecast by Application (2019-2026)
12 Bifidobacterium Longum Manufacturing Cost Analysis
12.1 Bifidobacterium Longum Key Raw Materials Analysis
12.1.1 Key Raw Materials
12.1.2 Price Trend of Key Raw Materials
12.1.3 Key Suppliers of Raw Materials
12.1.4 Market Concentration Rate of Raw Materials
12.2 Proportion of Manufacturing Cost Structure
12.2.1 Raw Materials
12.2.2 Labor Cost
12.2.3 Manufacturing Expenses
12.3 Manufacturing Process Analysis of Bifidobacterium Longum
13 Industrial Chain, Sourcing Strategy and Downstream Analysis
13.1 Bifidobacterium Longum Industrial Chain Analysis
13.2 Upstream Raw Materials Sourcing
13.3 Raw Materials Sources of Bifidobacterium Longum Major Manufacturers in 2018
13.4 Downstream Market and Representative Companies Analysis
13.4.1 Medicine Market Analysis
13.4.2 Others Market Analysis
13.4.5 Downstream Buyers
14 Sales Channel, Distributors, Traders and Dealers
14.1 Sales Channel
14.1.1 Direct Marketing
14.1.2 Indirect Marketing
14.1.3 Marketing Channel Development Trend
14.2 Market Positioning
14.2.1 Pricing Strategy
14.2.2 Brand Strategy
14.2.3 Target Client
14.3 Distributors, Traders and Dealers
15 Research Findings and Conclusion